Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology (Baltimore, Md.) [Hepatology] Journal article | | Title | Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. | | Author(s) | Paik YH, Schwabe RF, Bataller R, Russo MP, Jobin C, Brenner DA | | Institution | Department of Medicine, University of North Carolina at Chapel Hill, USA. | | Source | Hepatology 2003 May; 37(5):1043-55. | | MeSH | Animals Antigens, CD14 Blood Proteins Cells, Cultured Drosophila Proteins Hepatocytes Humans Intercellular Adhesion Molecule-1 Interleukin-8 JNK Mitogen-Activated Protein Kinases Lipopolysaccharides Liver Cirrhosis Membrane Glycoproteins Mice Mice, Inbred C3H Mitogen-Activated Protein Kinases Monocyte Chemoattractant Protein-1 NF-kappa B Receptors, Cell Surface Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Signal Transduction Toll-Like Receptor 4 Toll-Like Receptors Transcription Factor AP-1 Up-Regulation Vascular Cell Adhesion Molecule-1
| | Abstract | Bacterial lipopolysaccharide (LPS) stimulates Kupffer cells and participates in the pathogenesis of alcohol-induced liver injury. However, it is unknown whether LPS directly affects hepatic stellate cells (HSCs), the main fibrogenic cell type in the injured liver. This study characterizes LPS-induced signal transduction and proinflammatory gene expression in activated human HSCs. Culture-activated HSCs and HSCs isolated from patients with hepatitis C virus-induced cirrhosis express LPS-associated signaling molecules, including CD14, toll-like receptor (TLR) 4, and MD2. Stimulation of culture-activated HSCs with LPS results in a rapid and marked activation of NF-kappaB, as assessed by in vitro kinase assays for IkappaB kinase (IKK), IkappaBalpha steady-state levels, p65 nuclear translocation, NF-kappaB-dependent luciferase reporter gene assays, and electrophoretic mobility shift assays. Lipid A induces NF-kappaB activation in a similar manner. Both LPS- and lipid A-induced NF-kappaB activation is blocked by preincubation with either anti-TLR4 blocking antibody (HTA125) or Polymyxin B. Lipid A induces NF-kappaB activation in HSCs from TLR4-sufficient (C3H/OuJ) mice but not from TLR4-deficient (C3H/HeJ) mice. LPS also activates c-Jun N-terminal kinase (JNK), as assessed by in vitro kinase assays. LPS up-regulates IL-8 and MCP-1 gene expression and secretion. LPS-induced IL-8 secretion is completely inhibited by the IkappaB super repressor (Ad5IkappaB) and partially inhibited by a specific JNK inhibitor, SP600125. LPS also up-regulates cell surface expression of ICAM-1 and VCAM-1. In conclusion, human activated HSCs utilize components of TLR4 signal transduction cascade to stimulate NF-kappaB and JNK and up-regulate chemokines and adhesion molecules. Thus, HSCs are a potential mediator of LPS-induced liver injury. | | Language | eng | | Pub Type(s) | Journal Article
| | PubMed ID | 12717385 |
|
|
| | Advertise on this site.
| | |
|